Repare Therapeutics Inc. (RPTX) Tops Q2 EPS by 53c

Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q2 EPS of ($0.28), $0.53 better than the analyst estimate of ($0.81). Revenue for the quarter came in at $30.25 million versus the consensus estimate of $7.01 million.

For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
• Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts